Status:
COMPLETED
Noninvasive Methods in Diagnosing Coronary Heart Disease in Diabetic Patients
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Volda Hospital
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
40-75 years
Brief Summary
The purpose of this study is to investigate the prevalence of cardiac disease/coronary artery disease and diagnostic yield of different non-invasive methods in patients with type 2 diabetes 40-75 year...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Age at diagnosis \> 30 years
- Age at inclusion 40-75 years
Exclusion
- Angina pectoris
- Coronary angiography/stress-test diagnostic of coronary artery disease last 3 years
- Previous myocardial infarction, coronary bypass operation/PCI or heart failure
- Clinical indication for stress -testing
- Active bronchospasm excluding use of adenosine
- eGFR \< 30 ml/min/m2
- short estimated life expectancy due to cancer, chronic liver/renal diseases
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT01179165
Start Date
January 1 2011
End Date
December 1 2013
Last Update
March 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Volda Hospital HF
Volda, Norway, N-6100